AI is being deployed in the NHS to improve healthcare delivery across a broad range of activities
There isn’t any aspect of healthcare that isn’t being transformed by technology. The health-related technologies on display reflected the work that is being done to prevent illness, to deliver more effective treatments, and to reduce the growing cost of healthcare.
Ablacon, which is developing an atrial fibrillation (AFib) mapping system, has closed a $21.5 million Series A funding round led by Ajax Health.
Deep Lens, an AI-enabled clinical trial recruitment platform, has closed a $14 million Series A round led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.
TriNetX, a clinical research network, has closed its Series D investment round of $40 million led by Merck GHIF. The funding will be used for international expansion and product development.
MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.
The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
At HIMSS19, one theme seems to filter through all the buzz and activity: delivering value-based, patient-centred care.
For radiation oncologists, the laborious task of determining the treatment plan for cancer patients is being simplified and shortened with the application of AI software from Finnish company MVision.
Constrained by workforce shortages during the difficult winter period, Dartford and Gravesham NHS Trust deployed Current, an AI-enabled wearable platform, to remotely monitor patients after being discharged from hospital.